- Report
- November 2024
- 25 Pages
Germany
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 25 Pages
Taiwan
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 24 Pages
Saudi Arabia
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 26 Pages
Australia
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 27 Pages
Canada
From €995EUR$1,171USD£883GBP
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 23 Pages
China
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 25 Pages
Italy
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 27 Pages
France
From €995EUR$1,171USD£883GBP
- Report
- October 2022
- 42 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,171USD£883GBP
- Report
- January 2025
- 24 Pages
India
From €995EUR$1,171USD£883GBP
- Report
- January 2025
- 24 Pages
Singapore
From €995EUR$1,171USD£883GBP
- Report
- November 2024
- 26 Pages
Austria
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 22 Pages
Indonesia
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 21 Pages
Romania
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 23 Pages
Cameroon
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 22 Pages
North Macedonia
From €995EUR$1,171USD£883GBP
- Report
- October 2024
- 20 Pages
Tunisia
From €995EUR$1,171USD£883GBP

The Cold Sore Drug market is a subset of the Infectious Diseases Drugs market. Cold Sores, also known as fever blisters, are caused by the herpes simplex virus and are highly contagious. Cold Sore Drugs are used to treat the symptoms of the virus, such as pain, itching, and burning. These drugs can also help reduce the duration of the outbreak and prevent future outbreaks. Commonly used Cold Sore Drugs include antiviral medications, topical creams, and ointments.
The Cold Sore Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include Sanofi, Bayer, and Mylan. Show Less Read more